Life SciencesLiability
Contact

TL;DR

Five CRO professional liability and E&O architectures in 2026, sized by clinical phase, geographic scope, and service category. The single biggest sizing error generalist programs make is excluding clinical trial work from E&O coverage. Verify that exclusion language is absent before signing your next CTA.

Best of 2026

Best CRO E&O Architectures 2026.

CRO professional liability and E&O sizing depends on clinical phase, EU site exposure, dataset size, and service category. Below are the five architectures we see in practice in 2026, ranked by regulatory complexity and risk category.

  1. 01

    Phase 1 / single-site clinical CRO

    CROs supporting first-in-human studies at a single US site, typically with academic medical center partnerships.

    • - Professional liability / E&O at $2M.
    • - Cyber at $2M-$5M sized to single-study dataset.
    • - General liability $1M/$2M.
    • - No clinical trial work exclusion on the E&O.
    • - Survival of coverage past contract termination.
    • - Standard sponsor MSA compliance schedule.

    Premium range: $25K-$55K annually for a Phase 1 CRO at $3M-$15M revenue.

  2. 02

    Late-stage clinical CRO with EU sites

    CROs supporting Phase 2/3 studies at multi-site US + EU footprint. Most expensive and complex E&O placement category.

    • - Professional liability / E&O at $5M-$10M with explicit clinical trial monitoring scope.
    • - Cyber at $25M+ sized to PHI under management; HIPAA + GDPR breach response.
    • - EU GCP local insurance compliance per member-state requirements.
    • - Contingent cyber for eTMF, EDC, central lab vendor failures.
    • - Sponsor public-biotech downstream coverage for securities class action defense allocation.
    • - D&O for the operating entity scaled to PE/VC ownership exposure.

    Premium range: $220K-$650K annually for a late-stage CRO at $40M-$200M revenue.

  3. 03

    Pre-clinical / bioanalytical CRO

    GLP-regulated CROs performing toxicology, ADME, bioanalysis, in vitro/in vivo screening. No human subject exposure.

    • - Professional liability / E&O at $2M-$5M sized to sponsor regulatory submission impact.
    • - cGLP-aligned property with validation loss extension.
    • - Animal subject indemnity and IACUC exposure scope.
    • - Bioanalytical sample products liability for sample shipments.
    • - Cyber sized to sponsor proprietary data + IP.
    • - No clinical trial liability needed.

    Premium range: $45K-$130K annually for a pre-clinical CRO at $5M-$40M revenue.

  4. 04

    Central lab

    Centralized laboratories supporting clinical CROs and sponsors with kit distribution, sample processing, and result reporting.

    • - Professional liability / E&O for diagnostic accuracy at $5M-$10M.
    • - Products liability for kit distribution and shipping.
    • - Cyber at $10M-$25M sized to PHI volume across all sponsor studies.
    • - CAP/CLIA accreditation defense.
    • - Errors in result reporting that drive downstream regulatory decisions.
    • - Hospital reference-lab service agreement compliance.

    Premium range: $120K-$280K annually for a central lab at $25M-$100M revenue.

  5. 05

    IVRS / eClinical technology vendor

    Software-only CROs and eClinical vendors providing EDC, eTMF, IVRS, RTSM, and ePRO platforms.

    • - Technology E&O at $5M-$15M for software defects and data integrity errors.
    • - Cyber at $25M+ as the highest-exposure category in CRO ecosystem.
    • - Cloud platform contingent coverage (AWS/Azure/GCP failures).
    • - Specific endorsement for AI/ML model behavior in decision support systems.
    • - Sponsor MSA contingent cyber coverage flowing downstream from sponsor-CRO contracts.
    • - 21 CFR Part 11 validation defense and regulatory inspection support.

    Premium range: $180K-$500K annually depending on platform user count and clinical risk scope.

Size your CTL tower

Phase + sites + enrollment + geography returns a sponsor-side clinical trial liability coverage band.

Open the CTL Calculator